ALKS vs PODD
Alkermes Plc (ALKS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ALKS and PODD stock pages for the full models.
Not investment advice.